Alembic Pharmaceuticals' subsidiary, Alembic Global Holding SA, has established a new wholly-owned entity named Alembic Lifesciences Inc in the United States.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Competition page helps you compare Biocon Ltd. with its sector peers on key parameters.